Company Profile

IonOptix Corporation (AKA: IonOptix LLC )
Profile last edited on: 12/14/2023      CAGE: 480Y3      UEI: H762ZD9TLFU7

Business Identifier: Systems for fluorescent ion quantitation and cell dimension measurements
Year Founded
1990
First Award
1998
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

396 University Avenue
Westwood, MA 02090
   (617) 696-7335
   info@ionoptix.com
   www.ionoptix.com
Location: Single
Congr. District: 08
County: Norfolk

Public Profile

With offices in the USA, Europe and Asia, IonOptix Corporation - aka IonOptix LLC., makes quality ratiometric fluorescence and cell dimensioning data acquisition systems. Used in investigations ranging from characterization of excitation-contraction coupling to engineering cardiac tissue, the firm's clients include preclinical cardiovascular researchers working with isolated cardiomyocytes, tissue and blood vessels. Offering a range of high quality products, systems include those used for measuring calcium and contractility in isolated cardiomyocytes and vessels. The firm's MyoStretcher has a revolutionary OptiForce transducer for measuring force in cardiomyocytes, and culture pacing solutions for electrical stimulation of cultured cells. The new MultiCell high-throughput system is designed for the rigors of safety pharmacology and drug discovery screening in pharmaceutical research as well as the thorough characterization of EC coupling required for basic academic research - enabling simpler, faster acquisition and analysis of calcium and contractility without sacrificing the data fidelity.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $1,691,961
Project Title: High Throughput Screening of Pharmaceuticals Targeting Heart Cell Contractile Function
2000 2 NIH $774,600
Project Title: Quantitation Of Cardiac Myocyte Contractile Dynamics

Key People / Management

  Douglas L Tillotson -- Founder and President

  Bradley M Palmer

Company News

There are no news available.